64 related articles for article (PubMed ID: 16406501)
1. Expression of PKC isoforms in human melanocytic cells in situ.
Oka M; Nishigori C; Kageshita T; Hsu MY; Penmatcha S; Herlyn M
J Dermatol Sci; 2006 Feb; 41(2):157-61. PubMed ID: 16406501
[No Abstract] [Full Text] [Related]
2. Lack of protein kinase C (PKC)-beta and low PKC-alpha, -delta, -epsilon, and -zeta isozyme levels in proliferating human melanoma cells.
Krasagakis K; Fimmel S; Genten D; Eberle J; Quas P; Ziegler W; Haller H; Orfanos CE
Int J Oncol; 2002 Apr; 20(4):865-71. PubMed ID: 11894137
[TBL] [Abstract][Full Text] [Related]
3. Hormonal regulation of PKC: estrogen up-regulates PKCeta expression in estrogen-responsive breast cancer cells.
Karp G; Maissel A; Livneh E
Cancer Lett; 2007 Feb; 246(1-2):173-81. PubMed ID: 16580129
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C in melanoma.
Oka M; Kikkawa U
Cancer Metastasis Rev; 2005 Jun; 24(2):287-300. PubMed ID: 15986138
[TBL] [Abstract][Full Text] [Related]
5. Presenilin dependence of phospholipase C and protein kinase C signaling.
Dehvari N; Cedazo-Minguez A; Isacsson O; Nilsson T; Winblad B; Karlström H; Benedikz E; Cowburn RF
J Neurochem; 2007 Aug; 102(3):848-57. PubMed ID: 17437536
[TBL] [Abstract][Full Text] [Related]
6. Functional alterations in protein kinase C beta II expression in melanoma.
Voris JP; Sitailo LA; Rahn HR; Defnet A; Gerds AT; Sprague R; Yadav V; Caroline Le Poole I; Denning MF
Pigment Cell Melanoma Res; 2010 Apr; 23(2):216-24. PubMed ID: 20015121
[TBL] [Abstract][Full Text] [Related]
7. Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation?
Gilhooly EM; Morse-Gaudio M; Bianchi L; Reinhart L; Rose DP; Connolly JM; Reed JA; Albino AP
Melanoma Res; 2001 Aug; 11(4):355-69. PubMed ID: 11479424
[TBL] [Abstract][Full Text] [Related]
8. Abeta(1-42) stimulated T cells express P-PKC-delta and P-PKC-zeta in Alzheimer disease.
Miscia S; Ciccocioppo F; Lanuti P; Velluto L; Bascelli A; Pierdomenico L; Genovesi D; Di Siena A; Santavenere E; Gambi F; Ausili-Cèfaro G; Grimley PM; Marchisio M; Gambi D
Neurobiol Aging; 2009 Mar; 30(3):394-406. PubMed ID: 17850925
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of protein kinase C alpha and delta in testes of mouse at various stages of development.
Feng C; Zhang J; Gasana V; Fu W; Liu Y; Zong Z; Yu B
Cell Biochem Funct; 2005; 23(6):415-20. PubMed ID: 15540248
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C isoforms in normal and transformed cells of the melanocytic lineage.
Selzer E; Okamoto I; Lucas T; Kodym R; Pehamberger H; Jansen B
Melanoma Res; 2002 Jun; 12(3):201-9. PubMed ID: 12140376
[TBL] [Abstract][Full Text] [Related]
11. Parallel regulation of PKC-alpha and PKC-delta characterizes the occurrence of erythroid differentiation from human primary hematopoietic progenitors.
Lanuti P; Bertagnolo V; Gaspari AR; Ciccocioppo F; Pierdomenico L; Bascelli A; Sabatino G; Miscia S; Marchisio M
Exp Hematol; 2006 Dec; 34(12):1624-34. PubMed ID: 17157158
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of endogenous protein kinase Calpha on the dynamic change of carbachol-induced intracellular calcium response in different melanoma cells.
Wang H; Yu YQ; Liao WJ; Wang ZR; Lv YJ; Zhang YG; Gao TW
J Cell Physiol; 2009 Nov; 221(2):276-82. PubMed ID: 19626679
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C alpha but not PKCzeta suppresses intestinal tumor formation in ApcMin/+ mice.
Oster H; Leitges M
Cancer Res; 2006 Jul; 66(14):6955-63. PubMed ID: 16849539
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells.
Ghoul A; Serova M; Astorgues-Xerri L; Bieche I; Bousquet G; Varna M; Vidaud M; Phillips E; Weill S; Benhadji KA; Lokiec F; Cvitkovic E; Faivre S; Raymond E
Cancer Res; 2009 May; 69(10):4260-9. PubMed ID: 19417139
[TBL] [Abstract][Full Text] [Related]
15. Induction of senescence in diterpene ester-treated melanoma cells via protein kinase C-dependent hyperactivation of the mitogen-activated protein kinase pathway.
Cozzi SJ; Parsons PG; Ogbourne SM; Pedley J; Boyle GM
Cancer Res; 2006 Oct; 66(20):10083-91. PubMed ID: 17047072
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of cellular proliferation within transitional cell carcinoma: correlation of protein kinase C alpha/betaI expression and activity.
Aaltonen V; Koivunen J; Laato M; Peltonen J
J Histochem Cytochem; 2006 Jul; 54(7):795-806. PubMed ID: 16517978
[TBL] [Abstract][Full Text] [Related]
17. Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma.
Wu TT; Hsieh YH; Hsieh YS; Liu JY
J Cell Biochem; 2008 Jan; 103(1):9-20. PubMed ID: 17486587
[TBL] [Abstract][Full Text] [Related]
18. Rottlerin induces apoptosis via death receptor 5 (DR5) upregulation through CHOP-dependent and PKC delta-independent mechanism in human malignant tumor cells.
Lim JH; Park JW; Choi KS; Park YB; Kwon TK
Carcinogenesis; 2009 May; 30(5):729-36. PubMed ID: 19037087
[TBL] [Abstract][Full Text] [Related]
19. Characterization of patterns of expression of protein kinase C-alpha, -delta, -eta, -gamma and -zeta and their correlations to p53, galectin-3, the retinoic acid receptor-beta and the macrophage migration inhibitory factor (MIF) in human cholesteatomas.
Ghanooni R; Decaestecker C; Simon P; Gabius HJ; Hassid S; Choufani G
Hear Res; 2006 Apr; 214(1-2):7-16. PubMed ID: 16513304
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation and increased phosphorylation of protein kinase C (PKC) delta, mu and theta in the degenerating rd1 mouse retina.
Azadi S; Paquet-Durand F; Medstrand P; van Veen T; Ekström PA
Mol Cell Neurosci; 2006 Apr; 31(4):759-73. PubMed ID: 16503160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
